Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Sebastiaan JM Gaemers
Sanofi - Amsterdam
Amsterdam
Netherlands
Contact
Sanofi - Amsterdam
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
103
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients With Parkinson's Disease and a
GBA
Mutation: Results From Part 1 of the Randomised, Double-Blinded, Placebo-Controlled MOVES-PD Trial
Number of pages: 34
Posted: 25 Feb 2021
Judith Peterschmitt
,
Hidemoto Saiki
,
Taku Hatano
,
Thomas Gasser
,
Stuart H. Isaacson
, Sebastiaan JM Gaemers,
Pascal Minini
,
Stéphane Saubadu
,
Jyoti Sharma
,
Samantha Walbillic
,
Roy N. Alcalay
,
Gary Cutter
,
Nobutaka Hattori
,
Günter U. Höglinger
,
Kenneth Marek
,
Anthony Schapira
,
Clemens R. Scherzer
,
Tanya Simuni
,
Nir Giladi
,
Sergio Pablo Sardi
,
Tanya Z. Fischer
and
MOVES-PD Investigators Group
Sanofi - Massachusetts, The Tazuke Kofukai Medical Research Institute, Juntendo University, University of Tübingen, Parkinson’s Disease and Movement Disorders Center, Sanofi - Amsterdam, Sanofi - France, Sanofi - France, Sanofi - New Jersey, Sanofi - France, Department of Neurology and the Taub Institute, Columbia University, University of Alabama at Birmingham - School of Public Health, Juntendo University - Department of Neurology, Department of Neurology, Technische Universität München (TUM), Institute for Neurodegenerative Disorders, University College London - Department of Clinical and Movement Neurosciences, Harvard University - Brigham and Women's Hospital, Northwestern University, Tel Aviv Sourasky Medical Centre - Laboratory for Early Markers of Neurodegeneration, Sanofi - Massachusetts, Sanofi - Massachusetts and Independent
Downloads
103
(674,591)
View PDF
Download
Abstract:
Feedback